C Grandclément

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Multiple Myeloma

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

C Grandclément, C Estoppey, E Dheilly, M Panagopoulou, Thierry Monney, C Dreyfus, J Loyau, V Labanca, A Drake, S De Angelis, A Rubod, J Frei, L N Caro, S Blein, E Martini, M Chimen, Thomas Matthes, Z Kaya, Claire M Edwards, James R Edwards, E Menoret, C Kervoelen, Catherine Pellat-Deceunynck, P Moreau, M L Mbow, A Srivastava, Michael R Dyson, E A Zhukovsky, Mario Perro, Stefano Sammicheli
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma. Nature communications 15 (1) (2024)
C Grandclément, C Estoppey, E Dheilly, M Panagopoulou, Thierry Monney, C Dreyfus, J Loyau, V Labanca, A Drake, S De Angelis, A Rubod, J Frei, L N Caro, S Blein, E Martini, M Chimen, Thomas Matthes, Z Kaya, Claire M Edwards, James R Edwards, E Menoret, C Kervoelen, Catherine Pellat-Deceunynck, P Moreau, M L Mbow, A Srivastava, Michael R Dyson, E A Zhukovsky, Mario Perro, Stefano Sammicheli
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma. Nature communications 15 (1) (2024)
C Grandclément, C Estoppey, E Dheilly, M Panagopoulou, Thierry Monney, C Dreyfus, J Loyau, V Labanca, A Drake, S De Angelis, A Rubod, J Frei, L N Caro, S Blein, E Martini, M Chimen, Thomas Matthes, Z Kaya, Claire M Edwards, James R Edwards, E Menoret, C Kervoelen, Catherine Pellat-Deceunynck, P Moreau, M L Mbow, A Srivastava, Michael R Dyson, E A Zhukovsky, Mario Perro, Stefano Sammicheli
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma. Nature communications 15 (1) (2024)